The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

BRS spokesperson Manne Krishank gave a strong counter to the claims of Medicover Hospitals that the hospital had no links ...

Telangana attracts ₹36,000 crore investments in life sciences, becoming a global leader in pharmaceutical manufacturing and R ...

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...

A ‘Unified Digital Pharmacy Platform’ (UDPP) could serve as a digital healthcare solution for senior citizens, eliminating ...

Glenmark Pharma continued to benefit from its strong position in key chronic therapy areas, including respiratory and dermatology therapeutics, according to its latest, opens new tab annual report.

Source: Supplied. Industry experts, influencers, and pioneers from the world’s top pharmaceutical hubs will gather at the ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...